Lycopene for Hypertension and Factors Affecting Its Use: A Survey of Pharmacy Students

Authors

  • Basil Mohamed Department of Clinical and Administrative Pharmacy Sciences, College of Pharmacy, Howard University, NW, Washington DC 20059, USA
  • Ivan Mbami Department of Clinical and Administrative Pharmacy Sciences, College of Pharmacy, Howard University, NW, Washington DC 20059, USA
  • Bisrat Hailemeskel Department of Clinical and Administrative Pharmacy Sciences, College of Pharmacy, Howard University, NW, Washington DC 20059, USA
  • ABAAHP Department of Clinical and Administrative Pharmacy Sciences, College of Pharmacy, Howard University, NW, Washington DC 20059, USA

DOI:

https://doi.org/10.17140/DROJ-8-153

Keywords:

Lycopene; Dietary supplement, Hypertension; Cardiovascular.

Abstract

To better understand and assess the potential obstacles to the adoption of lycopene for treating high blood pressure.
Methods
A cross-sectional observational study was conducted by administering a survey to 42 Howard University College of Pharmacy students.
Descriptive statistics and risk estimates were calculated using statistical package for social studies (SPSS) software.
Results
Only 33.3% of students had ever heard of lycopene, and lycopene knowledge score was poor among 88% of respondents. Non-
D.C. residence, dietary supplement use and the belief that dietary supplements such as lycopene interact with prescription drugs and
should be used cautiously, were all correlated with a lesser risk of having poor lycopene knowledge. Annual income >$40,000 was
correlated with a greater risk of being in the poor lycopene knowledge group. Despite this data, 59.5% report that will incorporate
more lycopene into their diet.
Conclusion
Lycopene knowledge is generally poor among the observed cohort; however, this does not seem to be a great obstacle in the path
of adoption.

References

Ostchega Y, Fryar CD, Nwankwo T, Nguyen DT. Hypertension Prevalence among Adults Aged 18 and Over: United States, 2017–2018. NCHS Data Brief, no 364. Hyattsville, MD, USA: National Center for Health Statistics; 2020.

Imran M, Ghorat F, Ul-Haq I, et al. Lycopene as a natural an-tioxidant used to prevent human health disorders. Antioxidants (Basel). 2020; 9(8): 706. doi: 10.3390/antiox9080706 Original Research | Volume 8 | Number 1 |

Wolak T, Sharoni Y, Levy J, Linnewiel-Hermoni K, Stepensky D, Paran E. Effect of tomato nutrient complex on blood pres-sure: A double blind, randomized dose-response study. Nutrients. 2019; 11(5): 950. doi: 10.3390/nu11050950

Li X, Xu J. Lycopene supplement and blood pressure: an up-dated meta-analysis of intervention trials. Nutrients. 2013; 5(9): 3696-3712. doi: 10.3390/nu5093696

Sawardekar SB, Patel TC, Uchil D. Comparative evaluation of antiplatelet effect of lycopene with aspirin and the effect of their combination on platelet aggregation: An in vitro study. Indian J Pharmacol. 2016; 48(1): 26-31. doi: 10.4103/0253-7613.174428

May ME. What’s Lycopene? 2022. Web site. https://www.poi-Submit your article to this journal | https://openventio.org/submit-manuscript/ Original Research | Volume 8 | Number 1 | Hailemeskel B et al son.org/articles/lycopene. Accessed January 24, 2022.

Antartani R, Ashok K. Effect of lycopene in prevention of preeclampsia in high risk pregnant women. J Turk Ger Gynecol As-soc. 2011; 12(1): 35-38. doi: 10.5152/jtgga.2011.08

Alqrache A, Mostafa M, Ghabrah O, et al. Knowledge and pat-terns of dietary supplement use among students attending king Ab-dulaziz University in Saudi Arabia: A cross-sectional study. Inquiry. 2021; 58: 469580211020882. doi: 10.1177/00469580211020882

Samreen S, Siddiqui N, Wajid S, Mothana R, Almarfadi O. Prev-alence and use of dietary supplements among pharmacy students in Saudi Arabia. Risk Manag Healthc Policy. 2020; 13: 1523-1531. doi: 10.2147/RMHP.S256656

Downloads

Published

2022-02-24

How to Cite

Basil Mohamed, Ivan Mbami, Bisrat Hailemeskel, & ABAAHP. (2022). Lycopene for Hypertension and Factors Affecting Its Use: A Survey of Pharmacy Students. Diabetes Research, 8(1), 6–10. https://doi.org/10.17140/DROJ-8-153